Recent work demonstrating the effectiveness of targeting IH stem cells through inhibiting SOX18 using R-propranolol, may lead to more effective treatment of IH without the side effects of β-adrenergic blockade. This evidence concerns the gene SOX18 and isolated hemihyperplasia.